Related Experiment Video
Updated: May 29, 2026

Functional Characterization of Endogenously Expressed Human RYR1 Variants
Published on: June 9, 2021
Erythromelalgia accompanying rosuvastatin-associated myopathy
1The University of British Columbia, Vancouver, British Columbia, Canada.
Background:
Secondary erythromelalgia can occur due to various underlying medical disorders or drug toxicity.
Main Observations:
A 75-year old male developed acute secondary erythromelalgia following the onset of rosuvastatin use and associated myopathy. The illness was reversible after discontinuation of the pharmacological agent.
Conclusion:
Secondary erythromelalgia may occur after rosuvastatin use, but this and other dermatological toxicities are rare.
Related Concept Videos
Myocarditis III: Medical Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy